Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacy.

摘要

Drug coverage decisions made by managed care payers have the potential to influence millions of lives at a time The importance of making "evidence-based" coverage decisions has never been greater, particularly since the implementation of Medicare Part D in January 2006. For the first time since the inception of Medicare in 1965, all Medicare beneficiaries have access to drug coverage, albeit in different coverage schemes with some variation in out-of-pocket expense,